Relevance of viral phenotype in the early AIDS outcome of pediatric HIV-1 primary infection

Pediatric Research

Volumn 52, Issue 4, 2002, Pages 475-480

  Kopka, Julieta ^a   Batalla, Marcelo ^a   Mangano, Andrea ^a   Mecikovsky, Debora ^a   Bologna, Rosa ^a   Sen, Luisa ^a  

^a HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CELL LINE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; INFANT; LYMPHOCYTE DEPLETION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OUTCOMES RESEARCH; PHENOTYPE; PRESCHOOL CHILD; PRIMARY INFECTION; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS ISOLATION; VIRUS LOAD; VIRUS REPLICATION;

EID: 0036787097     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-200210000-00004     Document Type: Article

References (39)

1. Duliege AM, Messiah A, Blanche S, Tardieu M, Griscelli C, Spira A 1992 Natural history of human immunodeficiency virus type 1 infection in children: prognostic value of laboratory tests on the bimodal progression of disease. Pediatr Infect Dis J 11:630-635
2. Blanche S, Rouzioux C, Guihard Moscato ML, Veber F, Mayaux MJ, Jacomet C, Tricoire J, Deville A, Vial M, Firtion G, de Crepy A, Douard D, Robin M, Courpotin C, Ciraru-Vigneron N, le Deist F, Griscelli C, and the HIV Infection in Newborns French Collaborative Study Group 1989 A prospective study of infants born to women seropositive for human immunodeficiency virus type 1. N Engl J Med 320:1643-1648
3. European Collaborative Study 1991 Children born to women with HIV-1 infection: natural history and risk of transmission. Lancet 337:253-260
4. Asjö B, Morfeldt-Manson L, Albert J, Biberfeld G, Karlsson A, Lidman K, Fenyö EM 1986 Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection. Lancet 2:660-662
5. Cheng-Mayer C, Seto D, Tateno M, Levy J 1988 Biologic features of HIV-1 that correlate with virulence in the host. Science 240:80-82
6. Tersmette M, Lange JM, de Goede Rey, de Wolf F, Eeftink-Schattenkerk JKM, Schellekens PA, Coutinho RA, Huisman JG, Goudsmit J, Miedema F 1989 Association between biological properties of human immunodeficiency virus variants and risk for AIDS and AIDS mortality. Lancet 1:983-985
7. Fauci AS 1996 Host factors and the pathogenesis of HIV-induced disease. Nature 384:529-534
8. Mellors JN, Kingsley LA, Rinaldo CRJ, Todd JA, Hoo BS, Kokka RP, Gupta P 1995 Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med 122:573-579
9. van't Wout AB, Kootstra NA, Mulder-Kampinga A, Albrecht-van Lent N, Scherpbier HJ, Veenstra J, Boer K, Coutinho RA, Miedema F, Schuitemaker H 1994 Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral, and vertical transmission. J Clin Invest 94:2060-2067
10. Zhu T, Mo H, Wang N, Nam DS, Cao Y, Koup RA, Ho D 1993 Genotypic and phenotypic characterization of HIV-1 in patients with primary infection. Science 261:1179-1181
11. Tersmette M, de Goede REY, Al BJM, Winkel IN, Gruters RA, Cuypers HT, Huisman HG, Miedema F 1988 Differential syncytiun-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. J Virol 62:2026-2032
12. Schuitemaker H, Koot M, Kootstra NA, Dercksen MW, de Goede RE, van Steenwijk RP, Lange JM, Schattenkerk JK, Miedema F, Tersmette M 1992 Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population. J Virol 66:1354-1360
13. + cell depletion and progression to AIDS. Ann Intern Med 118:681-688
14. Richman D, Bozzettc SA 1994 The impact of the syncytium-inducing phenotype of human immunodeficiency virus on disease progression. J Infect Dis 169:968-974
15. De Rossi A, Giaquinto C, Ometto L, Mammano F, Zanotto C, Dunn D, Chieco-Bianchi L 1993 Replication and tropism of human immunodeficiency virus type 1 as predictors of disease outcome in infants with vertically acquired infection. J Pediatr 123:929-936
16. Ballota C, Vigano A, Riva C, Colombo MC, Salvaggio A, de Pasquale MP, Crupi L, Papagno L, Galli M, Moroni M, Principi N 1996 HIV type 1 phenotype correlates with the stage of infection in vertically infected children. AIDS Res Hum Retroviruses 12:1247-1253
17. Muñoz-Fernández MA, Navarro J, Obregón E, Arias RA, Gurbindo MD, Sampelayo TH, Fernández-Cruz E 1997 Immunological and virological markers of disease progression in HIV-infected children. Acta Paediatr Suppl 421:46-51
18. Resino S, Gurbindo D, Bellón Cano JM, Sánchez-Ramón S, Muñoz-Fernández MA 2000 Predictive markers of clinical outcome in vertically HIV-1-infected infants: a prospective longitudinal study. Pediatr Res 47:509-515
19. Gupta P, Urbach A, Cosentino L, Thampatty P, Brady M 1993 HIV-1 isolates from children with or without AIDS have similar in vitro biologic properties. AIDS 7:1561-1564
20. Fitzgibbon JE, Gaur S, Gavai M, Gregory P, Frenkel LD, John Jr JF 1998 Effect of the HIV-1 syncytium-inducing phenotype on disease stage in vertically-infected children. J Med Virol 55:56-63
21. Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ, VanDyke R, Bey M, Shearer W, Jacobson RL, Jimenez E, O'Neill E, Bazin B, Delfraissy J-F, Culnane M, Coombs R, Elkins M, Moye J, Stratton P, Balsley J, for the Pediatric AIDS Clinical Trials Group Protocol 076 Study Group 1994 Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 331:1173-1180
22. Denny T, Yogev R, Gelman R, Skuza C, Oleske J, Chadwick E, Cheng S-C, Connor E 1992 Lymphocyte subsets in healthy children during the first five years of life. JAMA 267:1484-1488
23. US Centers for Disease Control and Prevention 1994 Classification system for human immunodeficiency virus (HIV) infection in children under 13 years of age. MMWR Morb Mortal Wkly Rep 43:1-10
24. Hollinger FB, Bremer JW, Myers LE, Gold JW, McQuay L 1992 Standardization of sensitive human immunodeficiency virus coculture procedures and establishment of a multicenter quality assurance program for the AIDS Clinical Trials Group. The NIH/NIAID/DAIDS/ACTG Virology Laboratories. J Clin Microbiol 30:1787-1794
25. Japour AJ, Fiscus SA, Arduino J-M, Mayers DL, Reichelderfer PS, Kuritzkes DR 1994 Standardized microtiter assay for determination of syncytium-inducing phenotypes of clinical human immunodeficiency virus type 1 isolates. J Clin Microbiol 32:2291-2294
26. Albert J, Fenyo EM 1990 Simple, sensitive, and specific detection of human immunodeficiency virus type 1 in clinical specimens by polymerase chain reaction with nested primers. J Clin Microbiol 28:1560-1564
27. Spencer LT, Ogino MT, Dankner WM, Spector SA 1994 Clinical significance of human immunodeficiency virus type 1 phenotypes in infected children. J Infect Dis 169:491-495
28. Roos MTL, Lange JMA, de Goede REY, Coutinho RA, Schellekens PTA, Miedema F, Tersmette M 1992 Viral phenotype and immune response in primary human immunodeficiency virus type 1 infection. J Infect Dis 165:427-432
29. Nielsen C, Pedersen C, Lundgren JD, Gerstoft J 1993 Biological properties of HIV isolates in primary HIV infection: consequences for the subsequent course of infection. AIDS 7:1035-1040
30. Comelissen M, Mulder-Kampinga G, Veenstra J, Zorgdrager F, Kuiken C, Hartman S, Dekker J, van der Hoek L, Sol C, Coutinho R, Goudsmit J 1995 Syncytiuminducing (SI) phenotype suppression at seroconversion after intramuscular inoculation of a non-syncytium-inducing/SI phenotypically mixed human immunodeficiency virus population. J Virol 69:1810-1818
31. Fiore JR, Buccoliero G, Pezzotti P, Rezza G, Saracino A, Pastore G, Fenyo EM, Angarano G 1999 HIV-1 disease progression in women: role of the viral phenotype of the HIV-positive steady partner. AIDS 13:1801-1802
32. Baur A, Schwarz N, Ellinger S, Korn K, Harrer T, Mang K, Jahn G 1989 Continuous clearance of HIV in a vertically infected child. Lancet 2:1045
33. Rübsamen-Waigmann H, Williams WR, Bretram U, Von Briessen H 1989 Reversal of HIV-phenotype to fulminant replication on macrophages in perinatal transmission. Lancet 2:1155-1156
34. Connor RI, Ho DD 1994 Human immunodeficiency virus type 1 variants with increased replicative capacity develop during the asymptomatic stage before disease progression. J Virol 68:4400-4408
35. Van't Wout AB, Blaak H, Ran LJ, Brouwer M, Kuiken C, Schuitemaker H 1998 Evolution of syncytium-inducing and non-syncytium-inducing biological virus clones in relation to replication kinetics during the course of human immunodeficiency virus type 1 infection. J Virol 72:5099-5107
36. Shankarappa R, Margolick JB, Gange SY, Rodrigo AG, Upchurch D, Farzadegan H, Gupta P, Rinaldo CR, Learn GH, He X, Huang X-L, Mullins JI 1999 Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection. J Virol 73:10489-10502
37. Shearer WT, Quinn TC, LaRussa P, Lew JF, Mofenson L, Almy S, Rich K, Handelsman E, Diaz C, Pagano M, Smeriglio V, Kalish L, for the Women and Infants Transmission Study Group 1997 Viral load and disease progression in infants infected with human immunodeficiency virus type 1. N Engl J Med 336:1337-1342
38. European Collaborative Study 2002 Level and pattern of HIV-1 RNA viral load over age: differences between girls and boys? AIDS 16:97-104
39. Muñoz-Fernández MA, Obregón E, Navarro J, Börner C, Gurbindo MD, Sampelayo TH, Fernández Cruz E 1996 Relationship of virologic, immunologic, and clinical parameters in infants with vertically acquired human immunodeficiency virus type 1 infection. Pediatr Res 40:597-602